ROCKET: a Phase 3 Program Evaluating the Efficacy and Safety of Rocatinlimab in Moderate-to-severe Atopic Dermatitis.Emma Guttman-Yassky,Eric Simpson,Robert Bissonnette,Lawrence F Eichenfield,Kenji Kabashima,Paula C Luna, Janá Tresnak Hercogová,Lynda Spelman,Margitta Worm,Ehsanollah Esfandiari, Takahiro Arai, Hirotaka Mano, Prista Charuworn,Andrea Wang, Gregory KricorianImmunotherapy(2025)引用 0|浏览7AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要